Get latest articles and stories on India at LatestLY. Alembic Pharmaceuticals Ltd on Wednesday said it has received final approval from the US health regulator for its generic version of Arformoterol Tartrate inhalation solution indicated for long-term treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease. India News | Alembic Pharma Gets Final USFDA Nod for Generic Version of Arformoterol Tartrate Inhalation Solution.